Exporting hormones, vaccines and medicines from Argentina to the European Union covers 43 lines of the Combined Nomenclature 2026. Under the EU-Mercosur Agreement, 43 enter duty-free today. Data as of 30 October 2026, from the EU-Mercosur Interim Trade Agreement and the Combined Nomenclature 2026.
Lines covered
The guide takes every line of the Combined Nomenclature in force that starts with these codes, 43 lines in all. Each one has its own sheet.
- 2937 · Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including… · 9 lines
- 3002 · Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products… · 12 lines
- 3003 · Medicaments consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses… · 10 lines
- 3004 · Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or packings for retail… · 12 lines
Source Implementing Regulation (EU) 2025/1926, Annex I (Combined Nomenclature 2026)
The duty under the agreement
What each line pays today to enter the European Union from Argentina under the agreement, counted line by line with the same calculation as its sheet.
- 43lines enter duty-free with or without the agreement
Line by line
Grouped by heading. The code opens the sheet, with the year-by-year schedule and the source of every figure.
2937 · Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including… · 9 lines
| Line | Today under the agreement | Without it | Reaches 0 | Quota |
|---|---|---|---|---|
| 2937 11 00 Hormones › Somatotropin, its derivatives and structural analoguesCompare with other products (2937 11 00) | 0% | 0% | · | · |
| 2937 12 00 Hormones › Insulin and its saltsCompare with other products (2937 12 00) | 0% | 0% | · | · |
| 2937 19 00 Hormones › Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues › OtherCompare with other products (2937 19 00) | 0% | 0% | · | · |
| 2937 21 00 Hormones › Cortisone, hydrocortisone, prednisone (dehydrocortisone) and prednisolone (dehydrohydrocortisone)Compare with other products (2937 21 00) | 0% | 0% | · | · |
| 2937 22 00 Hormones › Halogenated derivatives of corticosteroidal hormonesCompare with other products (2937 22 00) | 0% | 0% | · | · |
| 2937 23 00 Hormones › Oestrogens and progestogensCompare with other products (2937 23 00) | 0% | 0% | · | · |
| 2937 29 00 Hormones › Steroidal hormones, their derivatives and structural analogues › OtherCompare with other products (2937 29 00) | 0% | 0% | · | · |
| 2937 50 00 Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesCompare with other products (2937 50 00) | 0% | 0% | · | · |
| 2937 90 00 Hormones › OtherCompare with other products (2937 90 00) | 0% | 0% | · | · |
3002 · Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products… · 12 lines
| Line | Today under the agreement | Without it | Reaches 0 | Quota |
|---|---|---|---|---|
| 3002 12 00 Antisera and other blood fractionsCompare with other products (3002 12 00) | 0% | 0% | · | · |
| 3002 13 00 Antisera › Immunological products, unmixed, not put up in measured doses or in forms or packings for retail saleCompare with other products (3002 13 00) | 0% | 0% | · | · |
| 3002 14 00 Antisera › Immunological products, mixed, not put up in measured doses or in forms or packings for retail saleCompare with other products (3002 14 00) | 0% | 0% | · | · |
| 3002 15 00 Antisera › Immunological products, put up in measured doses or in forms or packings for retail saleCompare with other products (3002 15 00) | 0% | 0% | · | · |
| 3002 41 10 Vaccines against SARS-related coronaviruses (SARS-CoV species)Compare with other products (3002 41 10) | 0% | 0% | · | · |
| 3002 41 90 Vaccines for human medicine › OtherCompare with other products (3002 41 90) | 0% | 0% | · | · |
| 3002 42 00 Vaccines for veterinary medicineCompare with other products (3002 42 00) | 0% | 0% | · | · |
| 3002 49 00 Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products › OtherCompare with other products (3002 49 00) | 0% | 0% | · | · |
| 3002 51 00 Cell therapy productsCompare with other products (3002 51 00) | 0% | 0% | · | · |
| 3002 59 00 Cell cultures, whether or not modified › OtherCompare with other products (3002 59 00) | 0% | 0% | · | · |
| 3002 90 10 Human bloodCompare with other products (3002 90 10) | 0% | 0% | · | · |
| 3002 90 30 Animal blood prepared for therapeutic, prophylactic or diagnostic usesCompare with other products (3002 90 30) | 0% | 0% | · | · |
3003 · Medicaments consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses… · 10 lines
| Line | Today under the agreement | Without it | Reaches 0 | Quota |
|---|---|---|---|---|
| 3003 10 00 Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivativesCompare with other products (3003 10 00) | 0% | 0% | · | · |
| 3003 20 00 Medicaments consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses › Other, containing antibioticsCompare with other products (3003 20 00) | 0% | 0% | · | · |
| 3003 31 00 Medicaments consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses › Containing insulinCompare with other products (3003 31 00) | 0% | 0% | · | · |
| 3003 39 00 Medicaments consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses › Other, containing hormones…Compare with other products (3003 39 00) | 0% | 0% | · | · |
| 3003 41 00 Medicaments consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses › Containing ephedrine or its…Compare with other products (3003 41 00) | 0% | 0% | · | · |
| 3003 42 00 Containing pseudoephedrine or its saltsCompare with other products (3003 42 00) | 0% | 0% | · | · |
| 3003 43 00 Containing norephedrine or its saltsCompare with other products (3003 43 00) | 0% | 0% | · | · |
| 3003 49 00 Medicaments consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses › Other, containing alkaloids…Compare with other products (3003 49 00) | 0% | 0% | · | · |
| 3003 60 00 Medicaments consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses › Other, containing…Compare with other products (3003 60 00) | 0% | 0% | · | · |
| 3003 90 00 Medicaments consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses › OtherCompare with other products (3003 90 00) | 0% | 0% | · | · |
3004 · Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or packings for retail… · 12 lines
| Line | Today under the agreement | Without it | Reaches 0 | Quota |
|---|---|---|---|---|
| 3004 10 00 Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses › Containing penicillins or derivatives thereof…Compare with other products (3004 10 00) | 0% | 0% | · | · |
| 3004 20 00 Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses › Other, containing antibioticsCompare with other products (3004 20 00) | 0% | 0% | · | · |
| 3004 31 00 Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses › Containing insulinCompare with other products (3004 31 00) | 0% | 0% | · | · |
| 3004 32 00 Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses › Containing corticosteroid hormones, their derivatives…Compare with other products (3004 32 00) | 0% | 0% | · | · |
| 3004 39 00 Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses › Other, containing hormones or other products of heading…Compare with other products (3004 39 00) | 0% | 0% | · | · |
| 3004 41 00 Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses › Containing ephedrine or its saltsCompare with other products (3004 41 00) | 0% | 0% | · | · |
| 3004 42 00 Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses › Containing pseudoephedrine (INN) or its saltsCompare with other products (3004 42 00) | 0% | 0% | · | · |
| 3004 43 00 Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses › Containing norephedrine or its saltsCompare with other products (3004 43 00) | 0% | 0% | · | · |
| 3004 49 00 Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses › Other, containing alkaloids or derivatives thereof › OtherCompare with other products (3004 49 00) | 0% | 0% | · | · |
| 3004 50 00 Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses › Other, containing vitamins or other products of heading…Compare with other products (3004 50 00) | 0% | 0% | · | · |
| 3004 60 00 Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses › Other, containing antimalarial active principles described…Compare with other products (3004 60 00) | 0% | 0% | · | · |
| 3004 90 00 Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses › OtherCompare with other products (3004 90 00) | 0% | 0% | · | · |
Sources EU-Mercosur Agreement, Appendix 2-A-1 (EU schedule) · Implementing Regulation (EU) 2025/1926, Annex I (Combined Nomenclature 2026)
Tariff-rate quotas
No line of this sector has a quota of the agreement for Argentina. Each reduction applies to any quantity.
Requirements
The requirements loaded for the lines of the sector, with how many each one covers. Each sheet has the detail for its line.
| Requirement | Type | Lines | Norm |
|---|---|---|---|
| Official control at an EU border control post · Handled in TRACES NT · sistema de control de partidas de la Unión Europea | Sanitary | 8 | Implementing Regulation (EU) 2021/632 |
- No line of this sector is listed in the EU plant health regulation. Implementing Regulation (EU) 2019/2072 · plant health
What Access2Markets lists in the EU
The requirements the European Commission's Access2Markets database assigns to the 43 lines checked.
| Requirement | Lines |
|---|---|
| Marketing requirements on Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) | 34 |
| Import and marketing requirements for medicinal products for human use | 22 |
| Import requirements for medicinal active substances | 21 |
| Import and marketing requirements for veterinary medicinal products | 12 |
| Marketing requirements on Classification, Labelling and Packaging (CLP) of chemicals substances and mixtures | 12 |
| CITES - Endangered Species Protection | 9 |
| Control of residues of veterinary medicines in animals and animal products for human consumption | 9 |
| Health control of products of animal origin not intended for human consumption | 8 |
| Technical standards for in vitro diagnostic medical devices | 6 |
| Marketing of products containing fluorinated greenhouse gases | 3 |
| Import requirements for seal products | 1 |
Source Access2Markets
What the European Union imports
In 2025 the European Union imported €136,597 million from outside the Union in 43 lines of this sector. From Argentina, €272.9 million (0.2% of the total). That is 3.4% of everything the European Union bought from Argentina in 2025.
The lines where Argentina sells the most
| Line | EU imports | From Argentina | Top supplier |
|---|---|---|---|
| 2937 19 00 Hormones › Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues › OtherCompare with other products (2937 19 00) | €22,462 million | €188.1 million (4th) | United States |
| 3002 49 00 Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products › OtherCompare with other products (3002 49 00) | €1,462 million | €37.6 million (5th) | United States |
| 3002 14 00 Antisera › Immunological products, mixed, not put up in measured doses or in forms or packings for retail saleCompare with other products (3002 14 00) | €13,599 million | €36.7 million (10th) | United States |
| 3002 13 00 Antisera › Immunological products, unmixed, not put up in measured doses or in forms or packings for retail saleCompare with other products (3002 13 00) | €1,501 million | €5.2 million (9th) | Switzerland |
| 3004 90 00 Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses › OtherCompare with other products (3004 90 00) | €43,702 million | €4.2 million (35th) | Switzerland |
| 3002 15 00 Antisera › Immunological products, put up in measured doses or in forms or packings for retail saleCompare with other products (3002 15 00) | €26,913 million | €395,568 (27th) | Switzerland |
| 3002 59 00 Cell cultures, whether or not modified › OtherCompare with other products (3002 59 00) | €224.4 million | €192,398 (9th) | Switzerland |
| 3002 12 00 Antisera and other blood fractionsCompare with other products (3002 12 00) | €8,643 million | €136,564 (34th) | United States |
| 3004 39 00 Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses › Other, containing hormones or other products of heading…Compare with other products (3004 39 00) | €6,029 million | €127,408 (18th) | China |
| 3004 20 00 Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses › Other, containing antibioticsCompare with other products (3004 20 00) | €1,497 million | €87,377 (28th) | Switzerland |
The totals leave out the trade Eurostat publishes as confidential.
Source Eurostat · Comext (DS-045409), 2025
This guide summarises the sheets of its lines. For a given product, open the sheet of its line, which also has the rule of origin, the paperwork in order and the calculator. See all the guides.